title: Mesenchymal stromal cell therapy: different sources exhibit different immunobiological properties.
authors.affiliation: 1 TSI Laboratory, University Heart Center Hamburg, Hamburg, Germany. 2 Department of Cardiothoracic Surgery, Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA. 3 Cardiovascular Research Center Hamburg (CVRC) and DZHK (German Center for Cardiovascular Research), partner site Hamburg/Kiel/Luebeck, Germany. 4 Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany.
authors.forename: Evgenios
authors.initials: E
authors.lastname: Neofytou
authors.forename: Tobias
authors.initials: T
authors.lastname: Deuse
authors.forename: Ramin E
authors.initials: RE
authors.lastname: Beygui
authors.forename: Sonja
authors.initials: S
authors.lastname: Schrepfer
mesh_terms: D015703:Antigens, CD / Q000378:metabolism; D002454:Cell Differentiation; D002469:Cell Separation; D064987:Cell- and Tissue-Based Therapy; D016922:Cellular Senescence / Q000276:immunology; D002986:Clinical Trials as Topic; D006801:Humans; D056747:Immunomodulation; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000166:cytology / Q000276:immunology* / Q000502:physiology; D019899:Paracrine Communication; D044968:Regenerative Medicine
chemical_list: D015703:Antigens, CD